46 gene sequencing test for cancer patients on the NHS

The first multi-gene DNA sequencing test that can help predict cancer patients’ responses to treatment has been launched in the National Health Service (NHS), thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust. The test uses the latest DNA sequencing techniques to detect mutations across 46 genes [...]

io-Synthesis Will Spotlight the New BNA Technology at AACR

Lewisville, TX, - The annual meeting for the American Associate of Cancer Research will be held April 6-10th in Washington, DC. As always, the meeting will be a platform for new ideas, research, and technologies. One of those new technologies has already been creating quite a buzz. Bio-Synthesis, Inc., an AACR exhibitor for over 18 [...]

Hologic Completes Sale of LIFECODES to Immucor

BEDFORD, Mass., -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that it has successfully completed its sale of the LIFECODES business unit to Immucor, Inc. Hologic has received $85 [...]

Nanyang Polytechnic and Pall to groom talent for Singapore’s biologics industry

Singapore,– Pall Filtration Pte Ltd, the Asia-Pacific headquarters of Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, will be collaborating with Nanyang Polytechnic (NYP) School of Chemical & Life Sciences (SCL) to develop talent for the rapidly growing biologics sector within Singapore’s S$13 billion pharmaceutical industry. The three-year collaboration encompasses student [...]

Xylem commemorates World Water Day through global water cooperation

WHITE PLAINS, N.Y., – Xylem Inc. (NYSE: XYL), a leading global water technology company addressing the world’s most challenging water issues, is commemorating World Water Day and the United Nations’ International Year of Water Cooperation by enhancing global partnerships to provide and protect safe water resources in communities around the world. According to the World [...]

Affymetrix Signs Contract With UK Biobank to Genotype 500,000 UK Individuals in the Largest Ever Study of Genetic and Environmental Factors in Disease and Personalized Medicine

SANTA CLARA, Calif -- Affymetrix, Inc. (NASDAQ: AFFX) today announced that it has signed a contract with UK Biobank to genotype 500,000 DNA samples donated by UK residents as part of a prospective epidemiological study of complex diseases that are of great relevance to public health. Affymetrix’ Axiom® Genotyping Solution will be used to generate [...]

NDIS Approval of Promega PowerPlex® Fusion System Assists Laboratories in Meeting Evolving Standards

Promega Corporation’s PowerPlex® Fusion System is now approved for use in laboratories that generate DNA records for the National DNA Index System (NDIS). NDIS is the U.S. national database containing over ten million offender profiles used to help authorities in solving criminal investigations nationwide, using the FBI’s CODIS system. This approval of PowerPlex Fusion follows [...]

Cellular Dynamics and Coriell Institute for Medical Research Awarded Multi-Million Dollar Grants from California Institute for Regenerative Medicine to Manufacture and Bank Stem Cell Lines

MADISON, WIS., –Cellular Dynamics International (CDI) and Coriell Institute for Medical Research today announced receiving two multi-million dollar grant awards from the California Institute for Regenerative Medicine (CIRM). CIRM awarded CDI $16 million to create 3 induced pluripotent stem cell (iPSC) lines for each of 3000 healthy and diseased donors. Tissue samples will be taken [...]

OriGene Technologies Raises $21.3 Million in Series C Funding

Rockville, MD –– OriGene Technologies, Inc., a leading genome wide product company for research and diagnostic applications, announced the completion of a $21.3 million Series C financing led by Qiming Venture Partners and Kleiner Perkins Caufield Byers China. OriGene’s previous investor IDG-Accel also participated in this round. "We are pleased with the high level of [...]

PerkinElmer Introduces a Novel Non-Invasive Near Infrared Imaging Agent for Toxicology Applications

The GFR-Vivo™ 680 imaging agent is the first fluorescent agent that allows researchers to measure glomerular filtration rate (GFR) non-invasively, in vivo in animals. GFR-Vivo 680, in combination with Fluorescence Molecular Tomography (FMT) imaging, provides a non-invasive approach to generate consistent GFR measurements in animal models of kidney disease, dysfunction, and drug toxicity. GFR is [...]

Access IBO on Knowledge Center